Australia
Tuberculosis profile
Population  2013 23 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.045 (0.045–0.046) 0.19 (0.19–0.2)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.02 (0.01–0.03)
Prevalence  (includes HIV+TB) 1.8 (0.71–3.3) 7.6 (3.1–14)
Incidence  (includes HIV+TB) 1.4 (1.3–1.6) 6.2 (5.8–6.8)
Incidence (HIV+TB only) 0.038 (0.029–0.046) 0.16 (0.13–0.2)
Case detection, all forms (%) 86 (79–93)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 2.3 (1.2–3.9) 4.2 (0.11–21)
MDR-TB cases among notified pulmonary
TB cases
16 (9–27) 1 (0–7)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 612   26
Pulmonary, clinically diagnosed 86   1
Extrapulmonary 512   13
       
Total new and relapse 1 250    
Previously treated, excluding relapses 6    
Total cases notified 1 256    
Among 1 250 new and relapse cases:
48 (4%) cases aged under 15 years; male:female ratio: 1.3
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 878 (143%) 33 (72%) 927
Laboratory-confirmed RR-/MDR-TB cases     26
Patients started on MDR-TB treatment     22
TB/HIV 2013 Number (%)
TB patients with known HIV status 975 (78)
HIV-positive TB patients 20 (2)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 82
Previously treated cases, excluding relapse, registered in 2012 57
HIV-positive TB cases, all types, registered in 2012 64
RR-/MDR-TB cases started on second-line treatment in 2011 42
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-07-04 Data: www.who.int/tb/data